Redox-Responsive Polycondensate Neoepitope for Enhanced Personalized Cancer Vaccine

55Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A versatile and highly effective platform remains a major challenge in the development of personalized cancer vaccines. Here, we devised a redox-responsive polycondensate neoepitope (PNE) through a reversible polycondensation reaction of peptide neoantigens and adjuvants together with a tracelessly responsive linker-monomer. Peptide-based neoantigens with diverse sequences and structures could be copolymerized with molecular adjuvants to form PNEs of high loading capacity for vaccine delivery without adding any carriers. The redox-responsive PNEs with controlled molecular weights and sizes efficiently targeted and accumulated in draining lymph nodes and greatly promoted the antigen capture and cross-presentation by professional antigen presenting cells. Mice immunized with PNEs showed markedly enhanced antigen-specific T cell response and the protective immunity against the tumor cell challenge.

Cite

CITATION STYLE

APA

Wei, L., Zhao, Y., Hu, X., & Tang, L. (2020). Redox-Responsive Polycondensate Neoepitope for Enhanced Personalized Cancer Vaccine. ACS Central Science, 6(3), 404–412. https://doi.org/10.1021/acscentsci.9b01174

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free